How Do I Give Oral Acyclovir for Neonatal HSV Safely?
At a Glance
After hospital treatment for neonatal HSV, many infants take liquid oral acyclovir for six months to suppress the virus. Caregivers should use the labeled syringe and written dosing plan, arrange blood monitoring, and seek care for warning signs.
In this answer
4 sections
Giving your baby an oral medication multiple times a day for six months is exhausting, but you are not alone, and your care team is there to support you. After your baby meets discharge criteria following intravenous (IV) hospital treatment, the standard transition for many infants with neonatal herpes simplex virus (HSV) involves a six-month course of suppressive therapy [1]. This means giving a daily, ongoing dose of liquid oral acyclovir to keep the virus inactive. While the strict schedule is challenging, consistent adherence is an important way to reduce risks, even though occasional timing errors can happen.
Why the Six-Month Course Matters
After the initial hospital treatment, the HSV virus remains in the body and can reactivate. Clinical studies support six months of suppression for several reasons:
- Supporting brain development: For babies who had central nervous system (CNS) involvement—particularly with the HSV-2 strain—completing the six months of oral acyclovir is associated with better neurodevelopmental outcomes [2][1].
- Preventing skin outbreaks: Suppressive therapy decreases the frequency of cutaneous (skin) recurrences [3][4]. Breakthrough skin recurrences can still occur even if you give every dose perfectly, which is why ongoing monitoring is required [3].
- Following the timeline: The specialist sets the planned stopping date. Discontinuing the medication early without medical advice increases the risk of severe neurologic recurrences [5][6]. However, an accidentally missed or delayed dose does not mean immediate harm; simply follow your team’s missed-dose plan.
The Practical Reality: Administering Liquid Acyclovir
Acyclovir has low bioavailability, meaning it is not easily absorbed through the stomach [7]. To maintain the right amount of medicine in the blood, it must be given frequently at specific clock-based intervals [7][8].
Safe Dosing and Pharmacy Tips
- Understand the concentration: The pharmacy compounds (mixes) the liquid acyclovir at a specific concentration (such as a certain number of milligrams per milliliter, or mg/mL). Always check the pharmacy label for the exact milliliter (mL) volume you should give. If you refill the prescription at a different pharmacy, verify that the concentration has not changed, as this would change the mL volume your baby needs [9].
- Use the oral syringe: Always measure the volume (mL) using the supplied oral syringe. Ensure you follow the pharmacy’s instructions for shaking the bottle, storing it (refrigerated versus room temperature), and noting the expiration date [9].
- Dose recalculations: Your baby’s care team calculates the medication based on developmental age and body surface area or weight [10][11]. Because babies grow rapidly, the prescribed volume will increase over time [10]. Never calculate or change the dose yourself; ensure the doctor reviews it at your follow-up appointments.
- Keep it calm: Administer the medicine slowly into the side of the cheek to prevent choking [12][13].
Handling Missed Doses and Spit-Ups
There is no universal medical rule for managing spit-ups, so you must have a written plan from your infectious disease team before leaving the hospital [14][15].
- Spit-ups and vomiting: Do not automatically repeat or double a dose. Write down the time, the estimated amount lost, and whether it was a small spit-up or forceful vomit, then contact your care team based on their provided guidelines.
- Missed doses: If you miss a dose, give it as soon as you remember, unless it is almost time for the next scheduled dose. Never double up on a dose to “catch up.”
Required Medical Monitoring
Because your baby is taking an antiviral medication for an extended time, they require regular monitoring for uncommon but important side effects.
- Blood counts: Acyclovir can cause neutropenia, which is a low Absolute Neutrophil Count (ANC) [16]. Neutrophils are white blood cells that fight infection. Your team will order periodic blood tests (often at 2 and 4 weeks, then monthly) to ensure your baby’s immune system is safe [17].
- Kidney function: Acyclovir is processed by the kidneys. Your doctor may check your baby’s kidney function using a blood test for creatinine, based on your baby’s medical history and hydration [18][16].
Warning Signs: When to Seek Care
Do not wait for a scheduled appointment if you notice signs of illness or a potential HSV recurrence.
- Same-day contact: Call your infectious disease team or pediatrician the same day if you see a new cluster of blisters, skin sores, or eye redness/lesions [19][3].
- Urgent / Emergency care: Seek immediate emergency evaluation if your baby experiences fever (especially important if they are being monitored for low blood counts), poor feeding, repeated vomiting, extreme sleepiness (lethargy), unusual irritability, abnormal movements or seizures, or breathing difficulty [20][14].
Common questions in this guide
How long will my baby need oral acyclovir after neonatal HSV treatment?
How should I measure liquid acyclovir for my baby?
What should I do if my baby spits up or vomits after acyclovir?
What should I do if I miss an acyclovir dose?
What monitoring does my baby need during oral acyclovir treatment?
When should I seek medical care while my baby is taking acyclovir?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is our exact written plan for redosing if my baby spits up or forcefully vomits immediately after taking the medication?
- 2.Who should we call after hours if my baby develops a fever, new skin blisters, or sudden changes in behavior?
- 3.What is the specific schedule for blood tests (such as ANC and creatinine) to monitor for side effects, and who will review the results?
- 4.How often will we have appointments to recalculate the medication volume (mL) as my baby grows?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (20)
- 1
Neurological Disorders Associated with Human Alphaherpesviruses.
Kawada JI
Advances in experimental medicine and biology 2018; (1045()):85-102 doi:10.1007/978-981-10-7230-7_5.
PMID: 29896664 - 2
Herpes Simplex Virus Infections of the Central Nervous System.
Whitley RJ
Continuum (Minneapolis, Minn.) 2015; (21(6 Neuroinfectious Disease)):1704-13 doi:10.1212/CON.0000000000000243.
PMID: 26633784 - 3
Real-World Data on Cutaneous Recurrences Following Neonatal Herpes Simplex Virus Disease.
Kimberlin DW
Journal of the Pediatric Infectious Diseases Society 2022; (11(11)):504-505 doi:10.1093/jpids/piac110.
PMID: 36264543 - 4
Neonatal Herpes Simplex Virus Infection: Epidemiology and Outcomes in the Modern Era.
Melvin AJ, Mohan KM, Vora SB, et al.
Journal of the Pediatric Infectious Diseases Society 2022; (11(3)):94-101 doi:10.1093/jpids/piab105.
PMID: 34894240 - 5
Neonatal Herpes Simplex Virus-1 Recurrence with Central Nervous System Disease in Twins after Completion of a Six-Month Course of Suppressive Therapy: Case Report.
Grondin A, Baudou E, Pasquet M, et al.
Neuropediatrics 2020; (51(3)):221-224 doi:10.1055/s-0039-3402011.
PMID: 31887772 - 6
Recurrent neonatal herpes simplex virus infection with central nervous system disease after completion of a 6-month course of suppressive therapy: Case report.
Kato K, Hara S, Kawada J, Ito Y
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2015; (21(12)):879-81.
PMID: 26390826 - 7
Acyclovir-Loaded Solid Lipid Nanoparticles: Optimization, Characterization and Evaluation of Its Pharmacokinetic Profile.
Hassan H, Bello RO, Adam SK, et al.
Nanomaterials (Basel, Switzerland) 2020; (10(9)) doi:10.3390/nano10091785.
PMID: 32916823 - 8
Herpes Zoster in a 9-Month-Old Immunocompetent Infant.
Alammar M
Archives of Iranian medicine 2025; (28(11)):657-659 doi:10.34172/aim.35002.
PMID: 41778437 - 9
Do pediatric oral suspension acetaminophen and ibuprofen product labeling and online resources facilitate intended use?
Loehfelm AM, Maxfield HA, Wallace LS
Exploratory research in clinical and social pharmacy 2023; (12()):100360 doi:10.1016/j.rcsop.2023.100360.
PMID: 38054192 - 10
Acyclovir Dosing Practices Across a Multicenter Cohort of Neonatal Intensive Care Units.
Foote HP, Thomassy H, Baquero L, et al.
The Pediatric infectious disease journal 2024; (43(12)):1156-1161 doi:10.1097/INF.0000000000004459.
PMID: 38920385 - 11
A Rare Case of Neonatal Disseminated Herpes Simplex Virus (HSV) With Concomitant Methicillin-Sensitive Staphylococcus aureus (MSSA) Bacteremia.
Sykes SR, Sharpe EL
Advances in neonatal care : official journal of the National Association of Neonatal Nurses 2022; (22(5)):400-407 doi:10.1097/ANC.0000000000000949.
PMID: 34596088 - 12
Safety of integrated preventive chemotherapy for neglected tropical diseases.
Ciciriello AM, Fairley JK, Cooke E, et al.
PLoS neglected tropical diseases 2022; (16(9)):e0010700 doi:10.1371/journal.pntd.0010700.
PMID: 36173948 - 13
An observational assessment of the safety of mass drug administration for trachoma in Ethiopian children.
Ciciriello AM, Addiss DG, Teferi T, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene 2022; (116(10)):917-923 doi:10.1093/trstmh/trac006.
PMID: 35106593 - 14
A Multicenter Study on Symptomatic Neonatal Herpes Simplex Virus Infection in Korea From 2008 to 2017.
Kim D, Kim KR, Choi JS, et al.
Journal of Korean medical science 2025; (40(42)):e282 doi:10.3346/jkms.2025.40.e282.
PMID: 41185580 - 15
Neonatal herpes simplex virus infections.
Pinninti SG, Kimberlin DW
Seminars in perinatology 2018; (42(3)):168-175 doi:10.1053/j.semperi.2018.02.004.
PMID: 29544668 - 16
Safety of High-dose Acyclovir in Infants With Suspected and Confirmed Neonatal Herpes Simplex Virus Infections.
Ericson JE, Gostelow M, Autmizguine J, et al.
The Pediatric infectious disease journal 2017; (36(4)):369-373 doi:10.1097/INF.0000000000001451.
PMID: 27977557 - 17
Exposure-safety relationship for acyclovir in the treatment of neonatal herpes simplex virus disease.
Ericson JE, Benjamin DK, Boakye-Agyeman F, et al.
Early human development 2022; (170()):105616 doi:10.1016/j.earlhumdev.2022.105616.
PMID: 35763957 - 18
Acute Kidney Injury During Treatment with Intravenous Acyclovir for Suspected or Confirmed Neonatal Herpes Simplex Virus Infection.
Downes KJ, Boge CLK, Baro E, et al.
The Journal of pediatrics 2020; (219()):126-132.e2 doi:10.1016/j.jpeds.2019.12.056.
PMID: 32037154 - 19
Congenital herpes simplex with ophthalmic and multisystem features: a case report.
Pereira SM, Lima RV, Muniz MCR, et al.
BMC pediatrics 2023; (23(1)):611 doi:10.1186/s12887-023-04423-1.
PMID: 38044450 - 20
Neonatal herpes simplex virus infection: From the maternal infection to the child outcome.
De Rose DU, Bompard S, Maddaloni C, et al.
Journal of medical virology 2023; (95(8)):e29024 doi:10.1002/jmv.29024.
PMID: 37592873
This page explains home administration of prescribed oral acyclovir after neonatal HSV treatment for informational purposes only and does not constitute medical advice. Use your infant’s written plan and contact the pediatric infectious disease team for individualized dosing, vomiting, or warning signs.
Get notified when new evidence is published on Congenital herpes simplex virus infection.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.